Teva Pharmaceutical Industries TEVA
NYSE TEVA
$40.18 -0.44 (-1.08%)
As of: Oct 22, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Short-Term Debt issuances (2020 - 2023)

Updated

Teva Pharmaceutical Industries' Short-Term Debt issuances came in at $700 million for FY2023.

Analysis

Teva Pharmaceutical Industries (TEVA) Short-Term Debt issuances (2020 - 2023) Analysis & Trends

Going back to FY2010, Teva Pharmaceutical Industries' Short-Term Debt issuances data covers 5 years.

  • Short-Term Debt issuances carries a four-year compound annual growth rate of 8.8% (FY2019 to FY2023).
  • Per Business Quant, earlier years put Short-Term Debt issuances at $700 million in FY2021 (+27.3%), $550 million in FY2020 (+10.0%) and $500 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Teva Pharmaceutical Industries 46.84 Bn 33.69 Bn 2.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 700.00 Mn
Dec 31, 2021 200.00 Mn
Dec 31, 2020 319.00 Mn
API Access

Teva Pharmaceutical Industries Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=TEVA&period=max&api_key=YOUR_API_KEY